Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,500Revenue (TTM) $M84.6Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $-1.5Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M45.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ANAC is held by these investors:

ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bell GraemeExecutive VP and CFO 2016-06-01Sell751$99.28-0.08view
Leonard Keith RDirector 2016-05-23Sell9,000$99.7-0.5view
Hove Anders DDirector 2016-05-16Sell353,881$99.59-0.39view
Sullivan Ryan TEVP and General Counsel 2016-04-29Sell3,125$66.3349.56view
Hove Anders DDirector 2016-04-08Sell229,301$71.139.52view
BERNS PAUL LPresident and CEO 2016-03-22Sell37,500$60.3164.48view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-03-02Sell9,000$63.8655.34view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-19Sell20,000$95.413.97view
Zane LeeSVP and Chief Medical Officer 2016-01-15Sell1,466$89.5710.75view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-04Sell855$112.28-11.65view

Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Royce Smaller-Companies Growth Fund Annual Letter Mar 19 2016 
    Royce Funds Comments on Anacor Pharmaceuticals Oct 12 2015 
    Staying Diversified in the Pursuit of Sustainable Growth - Royce Funds Commentary Oct 12 2015 
    Royce Smaller-Companies Growth Fund Shareholder Letter Sep 20 2015 
    Panic-Proofing the Small Investor Aug 26 2015 
    Anacor Pharmaceuticals’ Q4 Was A Solid One For Investors Mar 16 2015 
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 

    More From Other Websites
    New Product Launches May Boost Valeant’s Dermatology Revenue Mar 23 2017
    AnacorAcquisition Added Crisaborole to Pfizer’s Portfolio Nov 17 2016
    Four Key Deals: Analyzing Pfizer’s Impending Growth Oct 14 2016
    The Pfizer-Anacor Deal: A Review Sep 29 2016
    What Investors Should Know about the Pfizer-Anacor Deal Aug 29 2016
    Pfizer-Anacor Deal Completed in June 2016 Aug 12 2016
    Will Pfizer Book Another Healthy Quarter? Jul 22 2016
    What Can We Expect from the Pfizer-Anacor Deal? Jul 06 2016
    The Pfizer-Anacor Deal Wrapped Up in June: Now What? Jul 06 2016
    Pfizer Completes Anacor Acquisition Jun 24 2016
    Pfizer Completes Acquisition Of Anacor Jun 24 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 24 2016
    Why Pfizer (PFE) is a Great Stock to Buy for the Long Run Jun 23 2016
    Will A New Suitor For Anacor Emerge? Jun 15 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 08 2016
    How Wellcome and Gates charities profit from helping biotech May 30 2016
    How Wellcome and Gates charities profit from helping biotech May 30 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)